Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems

Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1223-5. doi: 10.1002/pds.3712. Epub 2014 Sep 29.

Authors

Carlos Bell¹, Aloka Chakravarty, Susan Gruber, Susan R Heckbert, Mark Levenson, David Martin, Jennifer C Nelson, Simone Pinheiro, Bruce M Psaty, Christian G Reich, Sebastian Schneeweiss, Azadeh Shoaibi, Sengwee Toh, Alexander M Walker

Affiliation

¹ Office of Medical Policy, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.

PMID: 25263307
DOI: 10.1002/pds.3712

No abstract available

Keywords: electronic medical records; insurance claims; pharmacoepidemiology; safety surveillance.

MeSH terms

Adverse Drug Reaction Reporting Systems / statistics & numerical data*
Angioedema / chemically induced*
Angiotensin-Converting Enzyme Inhibitors / adverse effects*
Electronic Health Records / statistics & numerical data
Humans
Pharmacoepidemiology
Research Design*

Substances

Angiotensin-Converting Enzyme Inhibitors